par Bozovic, Ivana ;de Azambuja, Evandro ;McCaskill-Stevens, Worta;Dinh, Phuong ;Cardoso, Fatima
Référence Cancer treatment reviews, 38, 5, page (329-339)
Publication Publié, 2012-08
Référence Cancer treatment reviews, 38, 5, page (329-339)
Publication Publié, 2012-08
Article révisé par les pairs
Titre: |
|
Auteur: | Bozovic, Ivana; de Azambuja, Evandro; McCaskill-Stevens, Worta; Dinh, Phuong; Cardoso, Fatima |
Informations sur la publication: | Cancer treatment reviews, 38, 5, page (329-339) |
Statut de publication: | Publié, 2012-08 |
Sujet CREF: | Cancérologie |
Mots-clés: | Aromatase inhibitors |
Breast cancer | |
Prevention | |
Raloxifene | |
Tamoxifen | |
MeSH keywords: | Antineoplastic Agents, Hormonal -- therapeutic use |
Aromatase Inhibitors -- therapeutic use | |
Breast Neoplasms -- drug therapy -- epidemiology -- prevention & control | |
Chemoprevention -- economics | |
Clinical Trials as Topic | |
Cost-Benefit Analysis | |
Female | |
Humans | |
Raloxifene -- therapeutic use | |
Risk Assessment | |
Selective Estrogen Receptor Modulators -- therapeutic use | |
Tamoxifen -- therapeutic use | |
Note générale: | Journal Article |
Review | |
SCOPUS: re.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0305-7372 |
info:doi/10.1016/j.ctrv.2011.07.005 | |
info:pii/S0305-7372(11)00172-1 | |
info:scp/84861193128 | |
info:pmid/21856081 |